Here’s Why IDEXX Laboratories (IDXX) Detracted in Q2
Baron Funds, an investment management company, released its “Baron Partners Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fundsmith LLP Terry Smith | 2,663,192 | $1,297,507,142 | -2% | 5.28% |
| 2. | GLG Partners Noam Gottesman | 198,185 | $96,555,732 | +27% | 0.24% |
| 3. | Millennium Management Israel Englander | 129,759 | $63,218,585 | -46% | 0.02% |
| 4. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 119,500 | $58,220,400 | -34% | 1.75% |
| 5. | Citadel Investment Group Ken Griffin | 77,372 | $37,695,639 | +84% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | Director | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | Director | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | Director | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | Director | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | Director | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $540.80 | 200 | Director | 161 | 2024-05-17 | Filing | |
| $559.33 | 680 | Officer | 10,711 | 2024-03-06 | Filing | |
| $558.88 | 3,290 | Officer | 11,391 | 2024-03-06 | Filing | |
| $557.94 | 4,134 | Officer | 14,681 | 2024-03-06 | Filing | |
| $562.98 | 1,404 | Director | 1,216 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,054,307 | $5,025,593,068 | 0.12% | |
| 2. | 8,377,667 | $4,650,024,068 | 0.1% | |
| 3. | 3,776,949 | $2,096,395,542 | 0.1% | |
| 4. | 2,937,760 | $1,630,603,688 | 0.62% | |
| 5. | 2,300,017 | $1,276,624,436 | 3.39% |
News See All
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Second Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
Should You Invest in IDEXX Laboratories (IDXX)?
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
50 Largest Companies in Every State in the US
The United States holds the title of the largest economy in the world, according to the IMF in 2024 the United States had a GDP of approximately $28.78 trillion, a GDP per capita of around $85,370, and...
23 Most Profitable Stocks of the Last 12 Months
In this article, we discuss the 23 most profitable stocks of the last 12 months.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.7.
11 Oversold Growth Stocks to Buy Right Now
In this article, we will take a look at the 11 oversold growth stocks to buy right now.
IDEXX Laboratories (IDXX) Gained 27% on Improved Operating Margins
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Strong Fiscal Q3 Earnings Pushed IDEXX Laboratories (IDXX) in Q4
Fred Alger Management, an investment management company, released its “Alger Mid Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. U.S.
IDEXX Laboratories (IDXX) Rebounded After Significant Drawdown From July Highs
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
